BrightFocus Foundation’s 2025 annual report celebrates groundbreaking research and public awareness.
Written By: BrightFocus Editorial Staff
BrightFocus Foundation’s 2025 annual report highlights groundbreaking donor-supported research and public awareness efforts over the last year to defeat Alzheimer’s disease, macular degeneration, and glaucoma.
In 2025, BrightFocus supported a portfolio of 186 active research grants across 16 countries seeking earlier detection methods, novel treatments, and pathways to cures for these diseases of mind and sight.
BrightFocus also raises awareness and empowers people with these diseases and their loved ones by sharing expert resources and information.
Learn more about our impact over the past year, including:
Read the annual report in magazine format or view a printable format (PDF).
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
Jimmy Liu, PhD, has joined BrightFocus as Director of Vision Science Programs, bringing deep expertise in eye disease research and a passion for advancing the next generation of vision treatments.
BrightFocus Foundation's new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
The proposed 2026 federal budget released by the Trump administration would deliver crippling cuts to the National Institutes of Health (NIH). These cuts would threaten essential progress in the fight against Alzheimer’s disease, macular degeneration, and glaucoma—diseases of mind and sight impacting 1 in 7 Americans over age 40.
Donate Now to Fund Critical Research
Your gift today can help drive innovation in Alzheimer's, macular degeneration, and glaucoma research. By donating, you’ll support life-changing research and provide valuable resources for those affected by these devastating diseases. Give now to fuel hope and bring us closer to finding cures.
